Abstract:Background: Diabetic kidney disease (DKD) is the most lethal complication of diabetes. Diverse programmed cell death (PCD) has emerged as a crucial disease phenotype that has the potential to serve as an indicator of renal function decline and can be used as a target for researching drugs for DKD. Methods: Microarray-based transcriptome profiling and single-nucleus transcriptome sequencing (snRNA-seq) related to DKD were retrieved from the Gene Expression Omnibus (GEO) database. 13 PCD-related genes (including alkaliptosis, apoptosis, autophagy-dependent cell death, cuproptosis, disulfidptosis, entotic cell death, ferroptosis, lysosome-dependent cell death, necroptosis, netotic cell death, oxeiptosis, parthanatos, and pyroptosis) were obtained from various public databases and reviews. The gene set variation analysis (GSVA) analysis was used to explore the pathway activity of these 13 PCDs in DKD, and the pathway activity of these PCDs in different renal cells was studied based on DKD-related snRNA-seq data. To identify the core PCDs that play a significant role in DKD, we analyzed the relationships between different types of PCD and immune infiltration, fibrosis-related gene expression levels, glomerular filtration rate (GFR), and diagnostic efficiency in DKD. Using the Weighted Gene Co-expression Network Analysis (WGCNA) algorithm, we screened for core death genes among the core PCDs and constructed a cell death-related signature (CDS) risk score based on the Least Absolute Shrinkage and Selection Operator (LASSO). Finally, we validated the predictive performance of the CDS risk score in an independent validation set. Results: We identified 4 core PCD pathways, namely entotic cell death, apoptosis, necroptosis, and pyroptosis in DKD, and further applied the WGCNA algorithm to screen 4 core death genes (CASP1, CYBB, PLA2G4A, and CTSS) and constructed a CDS risk score based on these genes. The CDS risk score demonstrated high diagnostic efficiency for DKD patients, and those with higher scores had higher levels of immune cell infiltration and poorer GFR. Conclusion: Our study sheds light on the fact that multiple PCDs contribute to the progression of DKD, highlighting potential therapeutic targets for treating this disease.

Podocyte programmed cell death in diabetic kidney disease: Molecular mechanisms and therapeutic prospects

Podocyte Death in Diabetic Kidney Disease: Potential Molecular Mechanisms and Therapeutic Targets

Potential Molecular Mechanisms and Therapeutic Targets

Modes of podocyte death in diabetic kidney disease: an update

Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects

New Insights into the Mechanisms of Pyroptosis and Implications for Diabetic Kidney Disease

Programmed Cell Death in Diabetic Nephropathy: A Review of Apoptosis, Autophagy, and Necroptosis

The Histologic Disorders and Underlying Mechanisms of Podocytes During Diabetes

Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy

Research progress on exosomes in podocyte injury associated with diabetic kidney disease

Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction

Non-Apoptotic Programmed Cell Death as Targets for Diabetic Retinal Neurodegeneration

Identification and analysis of diverse cell death patterns in diabetic kidney disease using microarray-based transcriptome profiling and single-nucleus RNA sequencing

Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy

Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy

Research Progress on Podocyte Pyroptosis in Diabetic Nephropathy

The critical role of dysregulated autophagy in the progression of diabetic kidney disease

Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives

Molecular pathways that drive diabetic kidney disease

Cellular crosstalk of glomerular endothelial cells and podocytes in diabetic kidney disease

Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update